Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jun 7:10:1221927.
doi: 10.3389/fcvm.2023.1221927. eCollection 2023.

Editorial: Novel approaches in cardiac imaging

Francesco Pelliccia  1 , Artur Dziewierz  2 , Giuseppe Pannarale  1 , Carlo Gaudio  1
Affiliations
Editorial

Editorial: Novel approaches in cardiac imaging

Francesco Pelliccia et al. Front Cardiovasc Med. .
No abstract available

Keywords: artificial inteligence-AI; cardiac imaging; computed tomography; echocardiography; magnetic resonance.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. López L, Rossello X, Romaguera D, Alonso-Gómez ÁM, Toledo E, Fortuny E, et al. The Palma echo platform: rationale and design of an echocardiography core lab. Front Cardiovasc Med. (2022) 9:909347. 10.3389/fcvm.2022.909347 - DOI - PMC - PubMed
    1. Ismail TF, Strugnell W, Coletti C, Božić-Iven M, Weingärtner S, Hammernik K, et al. Cardiac MR: from theory to practice. Front Cardiovasc Med. (2022) 9:826283. 10.3389/fcvm.2022.826283 - DOI - PMC - PubMed
    1. Del Torto A, Guaricci AI, Pomarico F, Guglielmo M, Fusini L, Monitillo F, et al. Advances in multimodality cardiovascular imaging in the diagnosis of heart failure with preserved ejection fraction. Front Cardiovasc Med. (2022) 9:758975. 10.3389/fcvm.2022.758975 - DOI - PMC - PubMed
    1. Marazzi G, Wajngarten M, Vitale C, Patrizi R, Pelliccia F, Gebara O, et al. Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease. Int J Cardiol. (2007) 120(1):79–84. 10.1016/j.ijcard.2006.08.082 - DOI - PubMed
    1. Marazzi G, Pelliccia F, Campolongo G, Quattrino S, Cacciotti L, Volterrani M, et al. Usefulness of nutraceuticals (armolipid plus) versus ezetimibe and combination in statin-intolerant patients with dyslipidemia with coronary heart disease. Am J Cardiol. (2015) 116(12):1798–801. 10.1016/j.amjcard.2015.09.023 - DOI - PubMed

Publication types

LinkOut - more resources